# Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy

> **NCT02844114** · PHASE2 · UNKNOWN · sponsor: **Gao Yajie** · enrollment: 60 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Ganoderma lucidum spore
- **DRUG:** Placebo
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT02844114
- **Lead sponsor:** Gao Yajie
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02844114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02844114, "Clinical Study of Ganoderma Lucidum Spore Combined With Chemotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02844114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*